JP Morgan Chase’s Omega Protein OME Stock Holding History

JP Morgan Chase’s Portfolio OME Stock Details OME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-153,009	Closed	-$2.57M	–	5710
2017 Q3	$2.57M	Buy	153,009 +80,731	+112%	+$1.31M	﹤0.01%	3010
2017 Q2	$1.29M	Buy	72,278 +56,840	+368%	+$1.06M	﹤0.01%	3295
2017 Q1	$310K	Sell	15,438 -19,783	-56%	-$461K	﹤0.01%	3898
2016 Q4	$882K	Buy	35,221 +30,742	+686%	+$726K	﹤0.01%	3502
2016 Q3	$105K	Buy	+4,479	New	+$105K	﹤0.01%	3854
2014 Q4	–	Sell	-298,702	Closed	-$3.73M	–	4461
2014 Q3	$3.73M	Buy	+298,702	New	+$4.16M	﹤0.01%	2546
2014 Q1	–	Sell	-10,500	Closed	-$129K	–	4084
2013 Q4	$129K	Sell	10,500 -8,914	-46%	-$105K	﹤0.01%	3874
2013 Q3	$198K	Buy	+19,414	New	+$182K	﹤0.01%	4052

JP Morgan Chase's OME Position: Q4 2017 in Review

JP Morgan Chase sold out of Omega Protein (OME) in Q4 2017, closing a stake of 153,009 shares — an estimated $2.57M sold.

JP Morgan Chase first reported a position in OME in Q3 2013 and held it in 8 quarters. The position peaked at $3.73M in Q3 2014. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.

JP Morgan Chase reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
JP Morgan Chase sold 153,009 Omega Protein shares in Q4 2017, an estimated $2.57M.
JP Morgan Chase first reported a position in Omega Protein in Q3 2013 and held it in 8 quarters.
JP Morgan Chase's Omega Protein position peaked at $3.73M in Q3 2014.
0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.

Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.